With the discovery of an unprecedented 74 preclinical drug candidates over the past 17 years, our streamlined integrated drug discovery process of identifying small molecules that possess suitable characteristics for development has proven to be extremely successful for our partners.

The process from initial target identification and validation, through assay development, high throughput screening, hit identification and lead optimization to preclinical candidate selection cannot be considered a routine activity. Significant intellectual and innovative input is required from experienced scientists across a variety of disciplines and backgrounds to discover a quality drug candidate. Our client-focused, collaborative approach creates true partnerships that anticipate challenges, overcome obstacles and move us forward together on the journey of getting new drugs to market.

Medicinal Chemists:
The Architects of Drug Discovery

Learn how our chemists can help move your programs forward in the drug discovery process.

Watch Video »

I need to...